A 38-year-old man from Mumbai presents with jaundice and elevated transaminases. Serological testing shows: HBsAg positive, anti-HBc IgM negative, anti-HBc IgG positive, HBeAg negative, anti-HBe positive, and HBV DNA detectable at low levels. All of the following are true regarding his status EXCEPT:

Question

Accepted Answer

B. He is in the window period of acute hepatitis B infection and is not infectious to others. ## Clinical Case: Chronic Hepatitis B with Low Replication Phase

### Serological Profile Interpretation

**Key Point:** The combination of HBsAg+, anti-HBc IgM−, anti-HBc IgG+, HBeAg−, anti-HBe+, and detectable HBV DNA defines **chronic hepatitis B in the low replication or "anti-HBe positive" phase**, NOT acute infection or window period.

### Diagnostic Criteria for Chronic HBV

Chronic hepatitis B is defined by:
1. **HBsAg persistence >6 months** (or clinical evidence of ongoing infection)
2. **Detectable HBV DNA** (confirms active viral replication)
3. **Elevated transaminases** (ALT/AST elevation indicates hepatic inflammation)

This patient meets all three criteria.

### Serological Pattern Analysis Table

| Clinical State | HBsAg | Anti-HBc IgM | Anti-HBc IgG | HBeAg | Anti-HBe | HBV DNA | Infectivity |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Acute HBV (early)** | + | + | − | + | − | + | High |
| **Window period** | − | + | − | − | − | + | High |
| **Chronic HBV (HBeAg+)** | + | − | + | + | − | High | High |
| **Chronic HBV (anti-HBe+)** | + | − | + | − | + | Low/detectable | Lower |
| **Recovery** | − | − | + | − | + | − | None |

### Why Option 4 is Incorrect

**Warning:** This patient is **NOT in the window period**. The window period is characterized by:
- HBsAg **negative**
- Anti-HBs **negative**  
- Anti-HBc IgM **positive** (diagnostic)
- HBV DNA **detectable**

This patient has **HBsAg positive**, which excludes the window period entirely. He is in chronic infection, not acute infection.

**Clinical Pearl:** The window period is a temporary state (weeks to months) during acute HBV infection when HBsAg has cleared but anti-HBs has not yet appeared. This patient's persistent HBsAg indicates chronic infection.

### Correct Statements Explained

**Option 1 (Correct):** HBsAg persistence defines chronic hepatitis B. Although we don't have the exact duration in the vignette, the clinical context (jaundice, elevated transaminases, anti-HBc IgG+) and serological pattern are consistent with chronic infection.

**Option 2 (Correct):** HBeAg− with anti-HBe+ indicates the lower replication phase ("anti-HBe positive chronic HBV"). Infectivity is reduced compared to the HBeAg+ phase, but the patient is still infectious.

**Option 3 (Correct):** Detectable HBV DNA confirms ongoing viral replication. Even in the anti-HBe+ phase, HBV DNA can be detectable (typically <10^5 copies/mL). Antiviral therapy decisions are based on HBV DNA level, ALT elevation, and degree of fibrosis (FIB-4, elastography).

**Mnemonic:** **Window ≠ Chronic** — **W**indow = HBsAg−, anti-HBc IgM+, anti-HBs−; **C**hronic = HBsAg+, anti-HBc IgG+, HBV DNA detectable.

Answer

A. He has chronic hepatitis B infection, as evidenced by HBsAg persistence for more than 6 months

Answer

C. The presence of anti-HBe with negative HBeAg suggests he is in a lower replication phase with reduced infectivity

Answer

D. His detectable HBV DNA indicates ongoing viral replication despite anti-HBe positivity, and he may require antiviral therapy based on ALT levels and HBV DNA quantitation

Explanation

Practice similar questions